should consider this as a snapshot of the present situation only, however. History teaches us that there can be long latency times from scientific breakthroughs to clinical applications and vice versa from clinical problems to new solutions from science. Nanomedicine, however, has the potential to act as a catalyst by bringing the disciplines in close contact with each other. This gives us confidence that a new culture of working together will emerge, making nanomedicine even more attractive.
Citius, altius, fortius
Over the past 15 years research into human disease has evolved at a tremendous rate: from the challenge to clone yet undiscovered human genes, through the subsequent decoding of the human genome up to today ' s possibilities to sequence it almost within a single day at costs of approximately 1000 US $. One needs to stay aware that science is a rapidly growing and ever accelerating area. A large part of the momentum was and is generated by enabling technologies. Nanomedicine will not be an exception. Reconsideration of strategies will become necessary in regular and shorter time intervals in order not to be left behind. The close proximity of clinicians and basic researchers in nanomedicine makes it a field predestined to undergo rapid changes thus defining a specific attractiveness for young researchers.
No decision without vision …
… could represent an exaggerated guiding principle but, in concrete terms, scientific journals have to be as dynamic and evolutionary as the field they are covering. This impacts all areas, including reader-friendly access, streamlined and easy procedures for authors and reviewers. New emerging fields and their importance for nanomedicine need to be identified. Inclusion of those into the aims and scopes of the journal will be mandatory. In terms of the above-mentioned, the journal will aim to continuously cover clinical and basic research related to nanomedicine. In upcoming issues, the European Journal of Nanomedicine intends to cover focused areas of special interest and to provide opportunities for young researchers to introduce their innovative fields. Corresponding calls will be published in the journal and on the webpage. Personally, I am delighted to be part of this process and look forward to developing and expanding the perspectives of the European Journal of Nanomedicine together with the Editorial office, the board of Editors, the readers and contributors.
